3 recruiting, 1 unknown. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Recruiting 2, Unknown 1 |
Follow Xiaotong Hou: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Reduced Vasopressors on Mortality in ECMO-supported Cardiogenic Shock Patients Vasopressor Exposure Levels - Cardiogenic Shock, Extracorporeal Membrane Oxygenation | Recruiting | Xiaotong Hou | 534 | 2025-02-26 | 2025-03-06 | |
| Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO nafamostat mesilate, unfractionated heparin group - Extracorporeal Membrane Oxygenation Complication | Not applicable | Recruiting | Xiaotong Hou | 80 | 2024-07-01 | 2025-09-25 |
| Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation bivalirudin, unfractionated heparin - Extracorporeal Membrane Oxygenation Complication | Not applicable | Recruiting | Xiaotong Hou | 154 | 2024-06-03 | 2026-04-06 |
| A Pilot Study of Sivelestat Sodium to Shorten Mechanical Ventilation in Acute Aortic Dissection Sivelestat sodium was given intravenously, Placebo was given intravenously - Acute Aortic Dissection | Not applicable | Unknown | Xiaotong Hou | 30 | 2023-05-01 | 2023-05-25 |
Heart Failure (1) · Shock, Cardiogenic (1)
Heparin (1) · bivalirudin (1) · nafamostat (1)
China (4)
Zhongtao Du, MD (2) · Liangshan Wang, MD (1) · Xiaomeng Wang, MD (1)
PMID 14758172, PMID 16554988, PMID 18410258, PMID 18722781, PMID 19011770, PMID 19447800, PMID 20354035, PMID 20376727, PMID 21881324, PMID 23295957, PMID 23596346, PMID 23631417, PMID 23774238, PMID 23834653, PMID 24075485, PMID 24750107, PMID 25705413, PMID 27756811, PMID 28442313, PMID 28792873, PMID 29118307, PMID 29707315, PMID 32030257, PMID 33353985